Innovative Clinical Research, Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Carlsbad CA United States (2010)

Organization Overview

First Clinical Trial
2014
NCT02008773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Innovative Clinical Research | Innovative Clinical Research, Inc. | Innovative Clinical Research Institute

Active Ingredients

Drugs in Phase 3 Trials (1)

endoxifen (1 trial)

Drugs in Phase 2 Trials (3)

dexamethasone (1 trial)

hydrocortisone (solu-cortef) (1 trial)

valaciclovir (Valtrex) (1 trial)

Drugs in Phase 1 Trials (2)

buprenorphine (1 trial)

ski-g-801 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 3)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Schizophrenia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6